Body Composition and COPD: A New Perspective

Wang, Xin; Liang, Qianqian; Li, Zheng; Li, Fengsen

doi:10.2147/copd.s394907

Cited by 9 publications

(2 citation statements)

References 119 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…However, these findings are consistent with the observation that a lower BMI in patients with COPD is a marker of clinically severe disease and greater mortality than patients with a greater BMI. 44 Our study has a number of notable strengths. This is the one of the largest studies to date to directly measure individualized, in-home NO 2 concentrations in people with COPD.…”

Section: Discussionmentioning

confidence: 97%

See 1 more Smart Citation

Pulmonary, inflammatory, and oxidative effects of indoor nitrogen dioxide in patients with COPD

McHugh,

Grady,

Collins

et al. 2023

Environmental Epidemiology

View full text Add to dashboard Cite

Introduction: Indoor nitrogen dioxide (NO2) sources include gas heating, cooking, and infiltration from outdoors. Associations with pulmonary function, systemic inflammation, and oxidative stress in patients with chronic obstructive pulmonary disease (COPD) are uncertain. Methods: We recruited 144 COPD patients at the VA Boston Healthcare System between 2012 and 2017. In-home NO2 was measured using an Ogawa passive sampling badge for a week seasonally followed by measuring plasma biomarkers of systemic inflammation (C-reactive protein [CRP] and interleukin-6 [IL-6]), urinary oxidative stress biomarkers (8-hydroxy-2'deoxyguanosine [8-OHdG] and malondialdehyde [MDA]), and pre- and postbronchodilator spirometry. Linear mixed effects regression with a random intercept for each subject was used to assess associations with weekly NO2. Effect modification by COPD severity and by body mass index (BMI) was examined using multiplicative interaction terms and stratum-specific effect estimates. Results: Median (25%ile, 75%ile) concentration of indoor NO2 was 6.8 (4.4, 11.2) ppb. There were no associations observed between NO2 with CRP, 8-OHdG, or MDA. Although the confidence intervals were wide, there was a reduction in prebronchodilator FEV1 and FVC among participants with more severe COPD (FEV1: –17.36 mL; –58.35, 23.60 and FVC: –28.22 mL; –91.49, 35.07) that was greater than in patients with less severe COPD (FEV1: –1.64 mL; –24.80, 21.57 and FVC: –6.22 mL; –42.16, 29.71). In participants with a BMI <30, there was a reduction in FEV1 and FVC. Conclusions: Low-level indoor NO2 was not associated with systemic inflammation or oxidative stress. There was a suggestive association with reduced lung function among patients with more severe COPD and among patients with a lower BMI.

show abstract

Section: Discussionmentioning

confidence: 97%

Section: Discussionmentioning

confidence: 99%